September 17, 2020

UAMS Researcher Strengthens Evidence for Connection Between COVID-19 and Pancreatitis

Amy Widner

Portrait of Dr. Inamdar

Patients with COVID-19 were at risk of developing pancreatitis in a study conducted by a University of Arkansas for Medical Sciences (UAMS) researcher using data from a large New York health system. The findings support the idea that pancreatitis should be included in the list of gastrointestinal symptoms of COVID-19, something that has been discussed…

September 16, 2020

UAMS Researcher Delgado-Calle Awarded $1.7 Million to Study Bone Health in Myeloma Patients

Linda Haymes

Jesus Delgado-Calle, Ph.D., an assistant professor at the University of Arkansas for Medical Sciences, has been awarded a National Cancer Institute grant of more than $1.7 million to study bone health in myeloma patients and the effectiveness of bone therapies.

LITTLE ROCK —Jesus Delgado-Calle, Ph.D., an assistant professor at the University of Arkansas for Medical Sciences (UAMS), has been awarded a National Cancer Institute grant of more than $1.7 million to study ways bone therapy might repair damaged bone and prevent or delay relapse in myeloma patients. Multiple myeloma, a cancer of the plasma cells…

September 9, 2020

SUPER Project Introduces Undergrads to Community-Based Research, Health Disparities

Amy Widner

Group shot of students with masks

Nine undergraduate students attended the SUPER Project Summer Institute in community-based research and health disparities in early August to prepare for health careers where they hope to make a difference in underserved communities. This allows them to conduct research with the guidance of mentors at their home institution and at UAMS as part of SUPER…

September 8, 2020

$1.9 Million Grant Funds DNA Damage Research by UAMS Scientist Justin Leung, Ph.D.

Susan Van Dusen

Justin Leung, PhD

A $1.9 million grant from the National Institute of General Medical Studies (NIGMS) will allow a scientist at the University of Arkansas for Medical Sciences (UAMS) to advance his research of DNA damage response (DDR) in cancer and genetic disorders.

September 4, 2020

COVID-19 Course for Medical Students Published for International Audience

Amy Widner

Zoom shot of researchers and teachers

Imagine teaching a class while using a new technology and the details of the lesson keep changing right up until the last second – all while student and teacher alike are experiencing massive disruptions in their personal lives. The professors at UAMS tasked with teaching the online COVID-19 course for the year three and year…

September 3, 2020

UAMS Research Expo Draws a Virtual Crowd

David Robinson

Yuet-Kin “Ricky” Leung, Ph.D. (left), won the 2020 Research Expo's Grand Door Prize, a manuscript submission fee to be paid by TRI. Leung also enjoyed the 2019 Expo, above with Nagai C. "Neville" Tam, Ph.D. (File Photo)

The UAMS Research Expo on Aug. 25 drew 184 registrants for the virtual event with 25 research service providers presenting via Zoom. Sponsored by the UAMS Translational Research Institute (TRI), the event included overviews of up to five minutes from representatives of the research services. Attendees were able to drop into the event to hear…

UAMS Researchers Awarded $11.4 Million Grant to Continue Study of Cancer Therapy Side Effects

Ben Boulden

The four new COBRE researchers are, left to right, Amanda Stolarz, Ping-Ching Hsu, Brendan Frett and Caroline Schinke.

LITTLE ROCK — Led by Marjan Boerma, Ph.D., a team of University of Arkansas for Medical Sciences (UAMS) researchers has received a five-year $11.4 million grant to continue research into the side effects of cancer therapies, including radiation and chemotherapies. The Centers for Biomedical Research Excellence (COBRE), a program of the National Institute of General…

September 2, 2020

UAMS Lung Cancer Researcher Contributes to Publication of Validation Protocols for Liquid Biopsy to Detect Cancer

Susan Van Dusen

Donald J. Johann, M.D.

Donald J. Johann, M.D., a lung cancer researcher at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), played an integral role in the publication of research related to liquid biopsy tests, or blood tests, for cancer.

September 1, 2020

UAMS’ Alan Tackett, Ph.D., Named to NIH Mechanisms of Cancer Therapeutics Study Section

Susan Van Dusen

Alan Tackett, PhD

Alan Tackett, Ph.D., was recently named a member of the National Institutes of Health (NIH) Mechanisms of Cancer Therapeutics-1 (MCT1) Study Section, one of the major review boards for evaluation of cancer research by the NIH Center for Scientific Review.

August 27, 2020

UAMS-Based Investigators Receive $39 Million Grant Renewal to Coordinate Multistate Clinical Trials in Infants & Children

Amy Widner

Portrait of Drs. Lee and Snowden

The University of Arkansas for Medical Sciences (UAMS) has been awarded $39 million from the National Institutes of Health (NIH) to continue to oversee an 18-site pediatric clinical trial network that provides children in medically underserved or rural areas access to clinical studies on environmental influences on early development. The Data Coordinating and Operations Center…

Next page